Dr. Rosen explains why the most aggressive B-cell lymphomas are the most curable and describes large B-cell lymphomas.
The most aggressive B-cell lymphomas, ironically, we have high cure-rates with modern therapy because the cells appear to be more sensitive to the chemotherapeutic agents that are available.
Diffuse large B-cell lymphomas are the most common lymphomas we see in adults. The cure-rate for diffuse large B-cell lymphomas in the range of about 50%, this is a disease that’s typically treated with chemotherapy and antibody therapy, combined.
About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.